報價延遲最少15分鐘:2025/07/07 00:45 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
29.65 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.34/-1.13
|
|
企業價值
298.03M
|
| 資產負債 |
|
每股賬面淨值
4.13
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
11.77M
|
|
每股收益
6.71
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/07 00:45 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical ActivatedCollagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel. |